Further investigations are needed to define the IL-15-dependent regulatory processes that control the aberrant activation of the NOTCH1 and PI3K/AKT pathways that could lead to leukemogenesis of T-ALL. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.